Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03859024 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
NCT03859024 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 48 participants.
The verdict
NCT03859024, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
Study Summary
The investigator's study aims to see if an enhanced recovery regimen of pain medications before and during surgery will decrease the use and risk of opioid pain medications as well as improve pain control in anterior urethroplasty patients. Participants will be randomized to one of two pain regimens (enhanced recovery regimen vs standard regimen).
Interventions
- DRUG Acetaminophen
- DRUG Bupivacaine
- DRUG Oxycodone
- DRUG Gabapentin
- DRUG celebrex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2019-03-22 |
| Est. Completion | 2023-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03859024
The ClinicalTrials.gov registry entry for NCT03859024 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Acetaminophen is the first listed.
NCT03859024 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03859024 about?
NCT03859024 is a clinical study titled "Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty". The investigator's study aims to see if an enhanced recovery regimen of pain medications before and during surgery will decrease the use and risk of opioid pain medications as well as improve pain control in anterior urethroplasty patients. Participants will be randomized to one of two pain regimens...
What is the current status of trial NCT03859024?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2019-03-22. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT03859024?
The interventions under investigation include: Acetaminophen (DRUG), Bupivacaine (DRUG), Oxycodone (DRUG), Gabapentin (DRUG), celebrex (DRUG).
Who is sponsoring clinical trial NCT03859024?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.